ALR Technologies, Inc. (OTC Pink: ALRT) operates as a medical device company, which develops technology for the treatment of diabetes. Shares of the diabetes treatment company surged 30%, during early trading on Friday, October 27, 2017. Over the past month, ALR Technologies, Inc. has seen average daily volume of 4.48 million shares. However, volume of 1.02 million shares or dollar volume of $53,040, has already exchanged hands on the day.

Shares of ALR Technologies, Inc. are jumping today, after the company announces that it has released a new video presentation showing its diabetes management system in action by doctors and healthcare providers. The latest video is the last of a series of six presentations that the company put out on its medical device. Here is the full press release detailing of the diabetes management system:

ALR Technologies, Inc. Press Release:

RICHMOND, VA — (Marketwired) — 10/23/17 — Following the recent FDA clearance of the Company’s Insulin Dose Adjustment feature and release of its patent pending Predictive A1C innovation, ALR Technologies, Inc. (“ALRT” or the “Company”) has released a new video presentation to show how health care providers are supported by the ALRT Diabetes Management System.

The latest video titled “Details of the ALRT Diabetes Management System” provides a tour of the ALRT diabetes management system from the perspective of a healthcare provider monitoring a group of diabetes patients under his or her care. The healthcare provider is able to view the progress and history of patient’s blood glucose date and the Predictive A1C trend for specific patients, and make decisions on adjustment of medicines within the system. ALRT provides in an integrated view, dosage information for all major diabetes medicines as well as the American Diabetes Association and American Association of Clinical Endocrinologists clinical guidelines for insulin dosage.

“Details of the ALRT Diabetes Management System” is the final video in a series of six videos released by ALRT last week, which highlight key features of the ALRT diabetes management system. To view the videos please go to the Company’s YouTube channel —

Note to Readers: screenshots of the ALRT Diabetes Management System include names of medicines prescribed for the treatment of Type 2 Diabetes, including the following:

Metformin and Metformin extended release Carbophage SR, Fortamet, Glucophage XR, Glumetza, Riomet

GLP-1-RA Adlyxin, Bydureon, Byetta, Tanzeum, Trulicity, Victoza

GLP-1-RA Combinations Soliqua 100-33, Xultophy

AGI Precose, Glyset

SGL2-I Farxiga, Invokana, Jardiance

SGL2-I Combinations Invokamet, Synjardy, Xigduo, Glyxambi

Sulfa Amaryl, Diabeta, Glucotrol, Micronase

Sulfa Combinations Amaryl M, Glucovance, Metaglip, Avandaryl, Duetact

GLN Glufast, Prandin, Starlix

GLN Combinations PrandiMet

DPP-4-I Januvia, Nesina, Onglyza, Tradjenta

DPP-4-I Combinations Janumet, Jentadueto, Kazano, Kombiglyze XR, Glyxambi, Oseni

TZD Actos, Avandia

TZD Combinations Actoplus Met, Avandamet, Oseni, Avandaryl, Duetact

INSULINS Intermediate Humulin N, Novolin N

Long acting Basaglar, Lantus, Levemir, Toujeo, Tresiba

Premixed Humalog Mix 50/50, Humalog Mix 75/25, Humulin 70/30, Novolin 70/30, Novolog Mix 70/30

Rapid acting Afrezza, Apidra, Flasp, Humalog, Novolog

Short acting Humulin R, Novolin R

About ALR Technologies Inc.ALR Technologies is a medical device company providing an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters. The System processes and streamlines collected data to support clinicians and caregivers to improve patient outcomes and assist health plans to optimize their investments in chronic disease care. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data. More information about ALR Technologies, Inc. can be found at

Add a Comment to this Post